{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:39Z","timestamp":1793388459271,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-I2M-1-034"],"award-info":[{"award-number":["2021-I2M-1-034"]}]},{"name":"the Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences","award":["2023-PT180-01"],"award-info":[{"award-number":["2023-PT180-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-024-03277-3","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T08:02:11Z","timestamp":1730448131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"3277_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"3277_CR2","doi-asserted-by":"crossref","unstructured":"Al-Ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, Kaddoumi A. Glial Cell-Mediated Neuroinflammation in Alzheimer\u2019s Disease. Int J Mol Sci 2022, 23.","DOI":"10.3390\/ijms231810572"},{"key":"3277_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer\u2019s Disease: Current Progress in Molecular Signaling and Therapeutics. Inflammation. 2023;46:1\u201317.","journal-title":"Inflammation"},{"key":"3277_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology. 2021;29:1669\u201381.","journal-title":"Inflammopharmacology"},{"key":"3277_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation. 2022;19:206.","journal-title":"J Neuroinflammation"},{"key":"3277_CR6","doi-asserted-by":"crossref","unstructured":"Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer\u2019s Disease Progression. Int J Mol Sci 2023, 24.","DOI":"10.3390\/ijms24031869"},{"key":"3277_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer\u2019s disease. Genome Med. 2023;15:6.","journal-title":"Genome Med"},{"key":"3277_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","volume":"629","author":"JA Wood","year":"1993","unstructured":"Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R. Cytokine indices in Alzheimer\u2019s temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res. 1993;629:245\u201352.","journal-title":"Brain Res"},{"key":"3277_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/BF00571510","volume":"89","author":"M Huell","year":"1995","unstructured":"Huell M, Strauss S, Volk B, Berger M, Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer\u2019s disease patients. Acta Neuropathol. 1995;89:544\u201351.","journal-title":"Acta Neuropathol"},{"key":"3277_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry. 2010;68:930\u201341.","journal-title":"Biol Psychiatry"},{"key":"3277_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/psyg.12218","volume":"17","author":"YS Kim","year":"2017","unstructured":"Kim YS, Lee KJ, Kim H. Serum tumour necrosis factor-\u03b1 and interleukin-6 levels in Alzheimer\u2019s disease and mild cognitive impairment. Psychogeriatrics. 2017;17:224\u201330.","journal-title":"Psychogeriatrics"},{"key":"3277_CR12","first-page":"170","volume":"5","author":"VK Khemka","year":"2014","unstructured":"Khemka VK, Ganguly A, Bagchi D, Ghosh A, Bir A, Biswas A, Chattopadhyay S, Chakrabarti S. Raised serum proinflammatory cytokines in Alzheimer\u2019s disease with depression. Aging Dis. 2014;5:170\u20136.","journal-title":"Aging Dis"},{"key":"3277_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0197-4580(99)00065-2","volume":"20","author":"WC Benzing","year":"1999","unstructured":"Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG, Brunden KR. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging. 1999;20:581\u20139.","journal-title":"Neurobiol Aging"},{"key":"3277_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0006-8993(00)03176-0","volume":"894","author":"J Apelt","year":"2001","unstructured":"Apelt J, Schliebs R. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 2001;894:21\u201330.","journal-title":"Brain Res"},{"key":"3277_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/156720509790147070","volume":"6","author":"L Ruan","year":"2009","unstructured":"Ruan L, Kang Z, Pei G, Le Y. Amyloid deposition and inflammation in APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Curr Alzheimer Res. 2009;6:531\u201340.","journal-title":"Curr Alzheimer Res"},{"key":"3277_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1517\/14728220903213426","volume":"13","author":"T Chiba","year":"2009","unstructured":"Chiba T, Yamada M, Aiso S. Targeting the JAK2\/STAT3 axis in Alzheimer\u2019s disease. Expert Opin Ther Targets. 2009;13:1155\u201367.","journal-title":"Expert Opin Ther Targets"},{"key":"3277_CR17","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1523\/JNEUROSCI.0519-10.2010","volume":"30","author":"J Wan","year":"2010","unstructured":"Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z, Ip NY. Tyk2\/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer\u2019s disease. J Neurosci. 2010;30:6873\u201381.","journal-title":"J Neurosci"},{"key":"3277_CR18","doi-asserted-by":"publisher","first-page":"110783","DOI":"10.1016\/j.intimp.2023.110783","volume":"124","author":"H Ni","year":"2023","unstructured":"Ni H, Liao Y, Zhang Y, Lu H, Huang Z, Huang F, Zhang Z, Dong Y, Wang Z, Huang Y. Levistilide A ameliorates neuroinflammation via inhibiting JAK2\/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer\u2019s disease mouse model. Int Immunopharmacol. 2023;124:110783.","journal-title":"Int Immunopharmacol"},{"key":"3277_CR19","doi-asserted-by":"publisher","first-page":"106227","DOI":"10.1016\/j.phrs.2022.106227","volume":"180","author":"P Gao","year":"2022","unstructured":"Gao P, Wang Z, Lei M, Che J, Zhang S, Zhang T, Hu Y, Shi L, Cui L, Liu J, et al. Daphnetin ameliorates A\u03b2 pathogenesis via STAT3\/GFAP signaling in an APP\/PS1 double-transgenic mouse model of Alzheimer\u2019s disease. Pharmacol Res. 2022;180:106227.","journal-title":"Pharmacol Res"},{"key":"3277_CR20","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s12035-016-9762-0","volume":"54","author":"SH Alawdi","year":"2017","unstructured":"Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David MO, Abdel-Wahhab MA. Neuroprotective Effect of Nanodiamond in Alzheimer\u2019s Disease Rat Model: a Pivotal Role for Modulating NF-\u03baB and STAT3 Signaling. Mol Neurobiol. 2017;54:1906\u201318.","journal-title":"Mol Neurobiol"},{"key":"3277_CR21","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1038\/s41598-024-53235-5","volume":"14","author":"T Phan Van","year":"2024","unstructured":"Phan Van T, Huyen Ton Nu Bao T, Leya M, Zhou Z, Jeong H, Lim CW, Kim B. Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF-\u03baB and STAT3 signaling pathways. Sci Rep. 2024;14:2744.","journal-title":"Sci Rep"},{"key":"3277_CR22","doi-asserted-by":"crossref","unstructured":"Dos Santos BL, Dos Santos CC, da Silva KC, Nonaka CKV, Souza BSF, David JM, de Oliveira JVR, Costa MFD, Butt AM, da Silva VDA, Costa SL. The Phytochemical Agathisflavone Modulates miR146a and miR155 in Activated Microglia Involving STAT3 Signaling. Int J Mol Sci 2024, 25.","DOI":"10.3390\/ijms25052547"},{"key":"3277_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jphs.2020.05.009","volume":"143","author":"M Choi","year":"2020","unstructured":"Choi M, Kim H, Yang EJ, Kim HS. Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer\u2019s disease. J Pharmacol Sci. 2020;143:290\u20139.","journal-title":"J Pharmacol Sci"},{"key":"3277_CR24","doi-asserted-by":"crossref","unstructured":"Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, Halle A, Petzold GC. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model. EMBO Mol Med 2019, 11.","DOI":"10.15252\/emmm.201809665"},{"key":"3277_CR25","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Ceyz\u00e9riat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, et al. The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases. J Neurosci. 2015;35:2817\u201329.","journal-title":"J Neurosci"},{"key":"3277_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","volume":"33","author":"C Chen","year":"2023","unstructured":"Chen C, Xu P. Cellular functions of cGAS-STING signaling. Trends Cell Biol. 2023;33:630\u201348.","journal-title":"Trends Cell Biol"},{"key":"3277_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21:548\u201369.","journal-title":"Nat Rev Immunol"},{"key":"3277_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7FAD mice. Nat Aging. 2023;3:202\u201312.","journal-title":"Nat Aging"},{"key":"3277_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13024-023-00672-x","volume":"18","author":"Y Huang","year":"2023","unstructured":"Huang Y, Liu B, Sinha SC, Amin S, Gan L. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. Mol Neurodegener. 2023;18:79.","journal-title":"Mol Neurodegener"},{"key":"3277_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/1570159X19666210924110144","volume":"20","author":"K Chen","year":"2022","unstructured":"Chen K, Lai C, Su Y, Bao WD, Yang LN, Xu PP, Zhu LQ. cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases. Curr Neuropharmacol. 2022;20:362\u201371.","journal-title":"Curr Neuropharmacol"},{"key":"3277_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gl\u00fcck S, Thacker VV, Favre L, Mangeat B, Kroese LJ, et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature. 2023;620:374\u201380.","journal-title":"Nature"},{"key":"3277_CR32","doi-asserted-by":"crossref","unstructured":"Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, Mattson MP, Croteau DL, Bohr VA. NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING. Proc Natl Acad Sci U S A 2021, 118.","DOI":"10.1073\/pnas.2011226118"},{"key":"3277_CR33","doi-asserted-by":"publisher","first-page":"175809","DOI":"10.1016\/j.ejphar.2023.175809","volume":"953","author":"D Gao","year":"2023","unstructured":"Gao D, Hao JP, Li BY, Zheng CC, Miao BB, Zhang L, Li YL, Li L, Li XJ, Zhang L. Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer\u2019s disease via cGAS-STING. Eur J Pharmacol. 2023;953:175809.","journal-title":"Eur J Pharmacol"},{"key":"3277_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2019.02.029","volume":"450","author":"J Pei","year":"2019","unstructured":"Pei J, Zhang Y, Luo Q, Zheng W, Li W, Zeng X, Li Q, Quan J. STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity. Cancer Lett. 2019;450:110\u201322.","journal-title":"Cancer Lett"},{"key":"3277_CR35","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1038\/s41598-021-86644-x","volume":"11","author":"MA Suter","year":"2021","unstructured":"Suter MA, Tan NY, Thiam CH, Khatoo M, MacAry PA, Angeli V, Gasser S, Zhang YL. cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells. Sci Rep. 2021;11:7243.","journal-title":"Sci Rep"},{"key":"3277_CR36","doi-asserted-by":"publisher","first-page":"215880","DOI":"10.1016\/j.canlet.2022.215880","volume":"547","author":"X Wang","year":"2022","unstructured":"Wang X, Hu R, Song Z, Zhao H, Pan Z, Feng Y, Yu Y, Han Q, Zhang J. Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity. Cancer Lett. 2022;547:215880.","journal-title":"Cancer Lett"},{"key":"3277_CR37","doi-asserted-by":"publisher","first-page":"114474","DOI":"10.1016\/j.expneurol.2023.114474","volume":"368","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xu M, Chen F, Su Y, Yu M, Xing L, Chang Y, Yan T. Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke. Exp Neurol. 2023;368:114474.","journal-title":"Exp Neurol"},{"key":"3277_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13567-020-00843-4","volume":"51","author":"Z Bo","year":"2020","unstructured":"Bo Z, Miao Y, Xi R, Zhong Q, Bao C, Chen H, Sun L, Qian Y, Jung YS, Dai J. PRV UL13 inhibits cGAS-STING-mediated IFN-\u03b2 production by phosphorylating IRF3. Vet Res. 2020;51:118.","journal-title":"Vet Res"},{"key":"3277_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41392-021-00800-3","volume":"6","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Zhang X, Lei X, Xiao X, Jiao T, Ma R, Dong X, Jiang Q, Wang W, Shi Y, et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct Target Ther. 2021;6:382.","journal-title":"Signal Transduct Target Ther"},{"key":"3277_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3\u201333.","journal-title":"Eur J Pharmacol"},{"key":"3277_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2:322\u20138.","journal-title":"Nat Protoc"},{"key":"3277_CR42","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848\u201358.","journal-title":"Nat Protoc"},{"key":"3277_CR43","doi-asserted-by":"crossref","unstructured":"Bromley-Brits K, Deng Y, Song W. Morris water maze test for learning and memory deficits in Alzheimer\u2019s disease model mice. J Vis Exp 2011.","DOI":"10.3791\/2920"},{"key":"3277_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn785","volume":"3","author":"SS Sisodia","year":"2002","unstructured":"Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer\u2019s disease: where do the presenilins fit in? Nat Rev Neurosci. 2002;3:281\u201390.","journal-title":"Nat Rev Neurosci"},{"key":"3277_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","volume":"54","author":"JY Hur","year":"2022","unstructured":"Hur JY. \u03b3-Secretase in Alzheimer\u2019s disease. Exp Mol Med. 2022;54:433\u201346.","journal-title":"Exp Mol Med"},{"key":"3277_CR46","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9440(10)63360-3","volume":"165","author":"T Bussi\u00e8re","year":"2004","unstructured":"Bussi\u00e8re T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am J Pathol. 2004;165:987\u201395.","journal-title":"Am J Pathol"},{"key":"3277_CR47","doi-asserted-by":"publisher","first-page":"13990","DOI":"10.1073\/pnas.222433299","volume":"99","author":"B Urbanc","year":"2002","unstructured":"Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2002;99:13990\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3277_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/pin.12520","volume":"67","author":"RH Takahashi","year":"2017","unstructured":"Takahashi RH, Nagao T, Gouras GK. Plaque formation and the intraneuronal accumulation of \u03b2-amyloid in Alzheimer\u2019s disease. Pathol Int. 2017;67:185\u201393.","journal-title":"Pathol Int"},{"key":"3277_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, F\u00e4ndrich M. Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol. 2015;129:167\u201382.","journal-title":"Acta Neuropathol"},{"key":"3277_CR50","doi-asserted-by":"crossref","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 2024.","DOI":"10.1093\/procel\/pwae026"},{"key":"3277_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","volume":"101","author":"C Venegas","year":"2017","unstructured":"Venegas C, Heneka MT. Danger-associated molecular patterns in Alzheimer\u2019s disease. J Leukoc Biol. 2017;101:87\u201398.","journal-title":"J Leukoc Biol"},{"key":"3277_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer\u2019s disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol. 2009;87:181\u201394.","journal-title":"Prog Neurobiol"},{"key":"3277_CR53","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"3277_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbi.2019.08.005","volume":"82","author":"A Escrig","year":"2019","unstructured":"Escrig A, Canal C, Sanchis P, Fern\u00e1ndez-Gayol O, Montilla A, Comes G, Molinero A, Giralt M, Gim\u00e9nez-Llort L, Becker-Pauly C, et al. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer\u2019s disease. Brain Behav Immun. 2019;82:145\u201359.","journal-title":"Brain Behav Immun"},{"key":"3277_CR55","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci. 2012;8:1237\u201347.","journal-title":"Int J Biol Sci"},{"key":"3277_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12974-020-02063-1","volume":"18","author":"M Recasens","year":"2021","unstructured":"Recasens M, Almolda B, P\u00e9rez-Clausell J, Campbell IL, Gonz\u00e1lez B, Castellano B. Chronic exposure to IL-6 induces a desensitized phenotype of the microglia. J Neuroinflammation. 2021;18:31.","journal-title":"J Neuroinflammation"},{"key":"3277_CR57","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/glia.23592","volume":"67","author":"A Nazmi","year":"2019","unstructured":"Nazmi A, Field RH, Griffin EW, Haugh O, Hennessy E, Cox D, Reis R, Tortorelli L, Murray CL, Lopez-Rodriguez AB, et al. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression. Glia. 2019;67:1254\u201376.","journal-title":"Glia"},{"key":"3277_CR58","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/nar\/gkad1184","volume":"52","author":"EJ Talbot","year":"2024","unstructured":"Talbot EJ, Joshi L, Thornton P, Dezfouli M, Tsafou K, Perkinton M, Khoronenkova SV. cGAS-STING signalling regulates microglial chemotaxis in genome instability. Nucleic Acids Res. 2024;52:1188\u2013206.","journal-title":"Nucleic Acids Res"},{"key":"3277_CR59","doi-asserted-by":"publisher","first-page":"111195","DOI":"10.1016\/j.cellsig.2024.111195","volume":"119","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Li Y, Liu Y, Wang X, Yang Y, Shi L. The cGAS\/STING signaling pathway is involved in sevoflurane induced neuronal necroptosis via regulating microglia M1 polarization. Cell Signal. 2024;119:111195.","journal-title":"Cell Signal"},{"key":"3277_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.04.009","volume":"548","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang B, Duan R, Liu Y. Mitochondrial DNA Leakage and cGas\/STING Pathway in Microglia: Crosstalk Between Neuroinflammation and Neurodegeneration. Neuroscience. 2024;548:1\u20138.","journal-title":"Neuroscience"},{"key":"3277_CR61","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12974-022-02511-0","volume":"19","author":"R Ding","year":"2022","unstructured":"Ding R, Li H, Liu Y, Ou W, Zhang X, Chai H, Huang X, Yang W, Wang Q. Activating cGAS-STING axis contributes to neuroinflammation in CVST mouse model and induces inflammasome activation and microglia pyroptosis. J Neuroinflammation. 2022;19:137.","journal-title":"J Neuroinflammation"},{"key":"3277_CR62","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, Turano E, Rossi B, Angiari S, Dusi S, et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. 2015;21:880\u20136.","journal-title":"Nat Med"},{"key":"3277_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2009.2.83","volume":"26","author":"A Henn","year":"2009","unstructured":"Henn A, Lund S, Hedtj\u00e4rn M, Schrattenholz A, P\u00f6rzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex. 2009;26:83\u201394.","journal-title":"Altex"},{"key":"3277_CR64","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jneumeth.2010.05.001","volume":"190","author":"DA Ryan","year":"2010","unstructured":"Ryan DA, Narrow WC, Federoff HJ, Bowers WJ. An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies. J Neurosci Methods. 2010;190:171\u20139.","journal-title":"J Neurosci Methods"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03277-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T09:03:38Z","timestamp":1730451818000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03277-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3277"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03277-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human samples were not used in this study. The study protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of the Institute of Laboratory Animal Sciences, CAMS & Comparative Medicine Center, PUMC (IACUC approval number: PJR18001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}